Nutra Pharma Corp., (OTC BB: NPHC) a biotechnology company that is developing drugs for HIV and Multiple Sclerosis, reports that Rik J Deitsch, Chief Executive Officer, was interviewed by The Wall Street Transcript ("TWST"). The interview has been included in TWST's February 2006 Biotechnology Report and is available to TWST's subscribers on their website www.twst.com.
